We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Deckers Outdoor
DECK
$13.3B
| $80.4K | 0.01% |
810
-37
| -4% | -$3.9K |
|
1052
Enliven Therapeutics
ELVN
$3.78B
| $80.2K | 0.01% |
1,581
+6
| +0.4% | +$255 |
|
1053
Vanguard Total International Stock ETF
VXUS
$153B
| $80.2K | 0.01% |
938
-5,102
| -84% | -$427K |
|
1054
Toast
TOST
$16.8B
| $80.1K | 0.01% |
2,880
-686
| -19% | -$17.9K |
|
1055
Packaging Corp of America
PKG
$22.7B
| $80.1K | 0.01% |
336
-90
| -21% | -$19.7K |
|
1056
Green Brick Partners
GRBK
$3.13B
| $79.6K | 0.01% |
995
+537
| +117% | +$37.1K |
|
1057
Krystal Biotech
KRYS
$9.88B
| $79.5K | 0.01% |
214
+140
| +189% | +$41.8K |
|
1058
IonQ
IONQ
$12.3B
| $79.4K | 0.01% |
1,491
+309
| +26% | +$15.7K |
|
1059
H&R Block
HRB
$5.18B
| $79.3K | 0.01% |
2,083
-438
| -17% | -$15.3K |
|
1060
Hyatt Hotels
H
$17.6B
| $79.3K | 0.01% |
409
-4
| -1% | -$701 |
|
1061
KB Home
KBH
$3.48B
| $79.2K | 0.01% |
1,266
-144
| -10% | -$7.49K |
|
1062
Argan
AGX
$7.98B
| $79.1K | 0.01% |
99
-14
| -12% | -$9.31K |
|
1063
FirstEnergy
FE
$28.9B
| $79K | 0.01% |
1,661
+107
| +7% | +$5.08K |
|
1064
Diamondrock Hospitality Co
DRH
$2.63B
| $78.8K | 0.01% |
6,471
| – | – |
|
1065
Nelnet
NNI
$4.79B
| $78.8K | 0.01% |
591
+349
| +144% | +$46.2K |
|
1066
Kulicke & Soffa
KLIC
$5.3B
| $78.5K | 0.01% |
587
-73
| -11% | -$7.15K |
|
|
BBT
1067
Beacon Financial Corp
BBT
$2.53B
| $78.3K | 0.01% |
2,572
+60
| +2% | +$1.8K |
|
1068
Vanguard Growth ETF
VUG
$216B
| $78K | 0.01% |
906
-510
| -36% | -$42.9K |
|
|
NAK
1069
Northern Dynasty Minerals
NAK
$885M
| $78K | 0.01% |
40,606
| – | – |
|
1070
Cheesecake Factory
CAKE
$4.21B
| $77.9K | 0.01% |
980
-12
| -1% | -$777 |
|
1071
Kinetik
KNTK
$3.71B
| $77.9K | 0.01% |
1,612
-324
| -17% | -$15.5K |
|
1072
IES Holdings
IESC
$12.5B
| $77.9K | 0.01% |
106
+1
| +1% | +$646 |
|
1073
Molina Healthcare
MOH
$10.3B
| $77.8K | 0.01% |
340
+263
| +342% | +$47.7K |
|
1074
Veeva Systems
VEEV
$30.3B
| $77.7K | 0.01% |
438
-671
| -61% | -$111K |
|
1075
Cleveland-Cliffs
CLF
$6.81B
| $77.4K | 0.01% |
8,243
+1,614
| +24% | +$17.7K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.